C07D 405/14
Containing three or more hetero rings
Official title: containing three or more hetero rings
C07D405/14 (Containing three or more hetero rings) appears on 8,952 US grants and 11,813 published applications in this corpus.
Search patents in C07D- Granted patents
- 8,952
- Published applications
- 11,813
- Assignees
- 2,764
- Inventors
- 25,884
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 5 | 0 |
| 1978 | 9 | 0 |
| 1979 | 4 | 0 |
| 1980 | 1 | 0 |
| 1981 | 5 | 0 |
| 1982 | 3 | 0 |
| 1983 | 10 | 0 |
| 1984 | 11 | 0 |
| 1985 | 27 | 0 |
| 1986 | 17 | 0 |
| 1987 | 30 | 0 |
| 1988 | 29 | 0 |
| 1989 | 35 | 0 |
| 1990 | 48 | 0 |
| 1991 | 55 | 0 |
| 1992 | 54 | 0 |
| 1993 | 91 | 0 |
| 1994 | 65 | 0 |
| 1995 | 61 | 0 |
| 1996 | 61 | 0 |
| 1997 | 99 | 0 |
| 1998 | 104 | 0 |
| 1999 | 99 | 0 |
| 2000 | 113 | 0 |
| 2001 | 132 | 26 |
| 2002 | 149 | 124 |
| 2003 | 141 | 246 |
| 2004 | 113 | 349 |
| 2005 | 130 | 338 |
| 2006 | 167 | 309 |
| 2007 | 192 | 349 |
| 2008 | 192 | 299 |
| 2009 | 219 | 417 |
| 2010 | 243 | 394 |
| 2011 | 257 | 367 |
| 2012 | 283 | 394 |
| 2013 | 344 | 450 |
| 2014 | 404 | 511 |
| 2015 | 468 | 603 |
| 2016 | 409 | 588 |
| 2017 | 525 | 561 |
| 2018 | 428 | 501 |
| 2019 | 448 | 618 |
| 2020 | 455 | 610 |
| 2021 | 369 | 553 |
| 2022 | 359 | 605 |
| 2023 | 333 | 802 |
| 2024 | 386 | 742 |
| 2025 | 456 | 619 |
| 2026 | 311 | 438 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- CDK inhibitors6 Oct 2026US 12,751,951 B2Genentech, Inc.
- Diaminopyrimidine carboxamide inhibitors of HPK16 Oct 2026US 12,753,163 B2Merck Sharp & Dohme Corp.
- CCR6 receptor modulators6 Oct 2026US 12,753,168 B2Idorsia Pharmaceuticals Ltd
- Preparation method and chiral sieving application of novel 12-crown-4 covalent organic frameworks6 Oct 2026US 12,753,169 B2Chongqing University of Arts and Sciences
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Antidegradant bis(dihydro and tetrahydroquinoline) compounds and uses thereof8 Oct 2026US 2026/0308127 A1Flexsys IP Holdings, LLC
- Cis-8-(3,5-Difluorophenyl)-8-(dimethylamino)-1,3-diazaspiro[4.5]decan-2-one derivatives8 Oct 2026US 2026/0308140 A1Gruenenthal GmbH
- 5-ht2a receptor inverse agonist, and preparation method therefor and use thereof8 Oct 2026US 2026/0308142 A1Luye Innomind Pharma Shijiazhuang Co., Ltd.
- Cdk2 inhibitors and methods of using same8 Oct 2026US 2026/0308145 A1Guangdong Touchstone Translational Research Institute Co., Ltd.
- Triazolyl-containing compounds8 Oct 2026US 2026/0308146 A1Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Most cited
By later US patents
- Backbone modified oligonucleotide analogs983US 5,602,240 ACiba-Geigy Corporation · 1997
- Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms772US 5,489,677 AIsis Pharmaceuticals, Inc. · 1996
- Conjugated 4'-desmethyl nucleoside analog compounds660US 5,608,046 AIsis Pharmaceuticals, Inc. · 1997
- Backbone modified oligonucleotide analogues637US 5,610,289 AIsis Pharmaceuticals, Inc. · 1997
- Polyamine conjugated oligonucleotides609US 5,138,045 AIsis Pharmaceuticals, Inc. · 1992